Dr Miller's research focuses on improving the sensitivity of paper microfluidic tests by using new nanomaterials and readout strategies, in order to detect the low levels of biomarkers needed for early diagnosis of infectious diseases. Paper microfluidics is a robust, low-cost technology which allows multi-step biochemical reactions with no user input.